FOLIC ACID HEALTH CLAIMS SPECIFIC TO DIETARY SUPPLEMENTS ALLOWED
This article was originally published in The Tan Sheet
Executive Summary
FOLIC ACID HEALTH CLAIMS SPECIFIC TO DIETARY SUPPLEMENTS ALLOWED under a finalized proposed rule slated to appear in the Federal Register the week of Jan. 3. The notice finalizes FDA's Oct. 14 proposed rule that tentatively authorized a rotate health claim in the labeling of supplements and foods recommended for use by women of child-bearing age for the prevention of neural tube defects (NTDs) in newborns. FDA emphasized, however, that the soon-to-be published rule "is deemed to be a final regulation only with respect to dietary supplements."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning